Publications by authors named "Hyung-Suk Cho"

Background: The association between leukapheresis (LK) as a treatment option for hyperleukocytosis (HL) in patients with acute myeloid leukemia (AML) remains controversial.

Methods: Data were extracted from the electronic medical record for 2801 patients with AML between April 2009 and December 2019. LK was performed when the leukocyte count was ≥100 × 10 /L at the time initial bone marrow examination.

View Article and Find Full Text PDF

Background: Granulocyte transfusions (GTs) have been used to treat infections in neutropenic patients undergoing chemotherapy or hematopoietic stem cell transplantation. However, there is persistent controversy regarding their outcomes. We aimed to analyze accumulated clinical and laboratory data from patients with acute myeloid leukemia (AML) who underwent GT at our institution in the last 10 years to determine optimal parameters to estimate the GT effect.

View Article and Find Full Text PDF

Small-bowel tumors, both benign and malignant, are rare lesions that clinicians often do not encounter, accounting for less than 2% of gastrointestinal malignancies. Usually, benign small-bowel tumors, including polyps, are asymptomatic. The diagnosis of small-bowel tumors is difficult because of an often-delayed presentation and nonspecific signs and symptoms.

View Article and Find Full Text PDF

Anal gland/duct cyst (AGC) is rare and observed in only 0.05% of patients undergoing anal surgery. AGC is thought to be a retention cyst in the anal gland and arises when an obstruction of the anal duct causes fluid collection in the anal gland.

View Article and Find Full Text PDF

Hidradenoma papilliferum is a rare benign cystic tumor that originates from apocrine glands or anogenital mammary glands. Here, we describe 2 cases of hidradenoma papilliferum of the anus. Two female patients aged 39 and 35 presented with perianal masses with hemorrhoids.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Hyung-Suk Cho"

  • - Hyung-Suk Cho's recent research focuses on the treatment and management of acute myeloid leukemia (AML), specifically assessing the effectiveness of leukapheresis and granulocyte transfusions to improve clinical outcomes in patients with hyperleukocytosis and infections respectively.
  • - A significant study published in December 2023 examined the impact of leukapheresis on early survival rates in AML patients, utilizing a large sample of 2801 cases, and aimed to clarify its controversial role in treatment protocols.
  • - Additionally, Cho's work includes investigating rare cases and conditions related to gastrointestinal and anal pathologies, as seen in several case reports published in the field of colorectal health, highlighting his diverse expertise within clinical medicine.*